Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-01-28 Purchase |
2021-02-01 5:31 pm |
VYNE Therapeutics Inc. | VYNE | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
4,219,409 | $2.37 | $9,999,999 | 27,095,819 (Indirect) |
View |
| 2021-01-25 Purchase |
2021-01-27 5:43 pm |
Athira Pharma Inc. | ATHA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Director 10% Owner |
311,111 | $22.5 | $6,999,998 | 3,425,916 (Indirect) |
View |
| 2021-01-20 Sale |
2021-01-26 9:57 pm |
SCYNEXIS INC | SCYX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
599,000 | $7.8555 | $4,705,431 | 1,800,000 (Indirect) |
View |
| 2021-01-20 Sale |
2021-01-22 9:12 pm |
Motus GI Holdings Inc. | MOTS | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
1,550,000 | $1.6342 | $2,533,078 | 2,660,542 (Indirect) |
View |
| 2021-01-19 Purchase |
2021-01-21 5:24 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
1,368,421 | $9.5 | $13,000,000 | 8,703,879 (Indirect) |
View |
| 2021-01-07 Purchase |
2021-01-11 9:53 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
1,050,000 | $8.7644 | $9,202,668 | 7,335,458 (Indirect) |
View |
| 2020-11-23 Purchase |
2020-11-24 08:00 am |
MeiraGTx Holdings plc | MGTX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Director 10% Owner |
500,000 | $12.85 | $6,425,000 | 6,933,277 (Indirect) |
View |
| 2020-10-27 Purchase |
2020-10-29 8:00 pm |
Cerevel Therapeutics Holdings Inc. | CERE | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Director |
3,000,000 | $10 | $30,000,000 | 3,157,295 (Indirect) |
View |
| 2020-10-20 Purchase |
2020-10-22 8:34 pm |
ARYA Sciences Acquisition Corp II | ARYB | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Director |
157,295 | $10.02 | $1,576,838 | 157,295 (Indirect) |
View |
| 2020-09-22 Purchase |
2020-09-22 7:11 pm |
Athira Pharma Inc. | ATHA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD 10% Owner |
1,058,824 | $17 | $18,000,008 | 3,114,805 (Indirect) |
View |
| 2020-09-15 Purchase |
2020-09-16 08:30 am |
Quotient Ltd | QTNT | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
2,911,764 | $4.25 | $12,374,997 | 16,200,818 (Indirect) |
View |
| 2020-09-14 Purchase |
2020-09-15 08:30 am |
ALBIREO PHARMA INC. | ALBO | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
400,000 | $40 | $16,000,000 | 2,360,139 (Indirect) |
View |
| 2020-09-10 Purchase |
2020-09-14 3:47 pm |
Athenex Inc. | ATNX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
2,000,000 | $11.02 | $22,048,000 | 13,532,467 (Indirect) |
View |
| 2020-07-09 Purchase |
2020-07-13 4:30 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
3,200,000 | $4.25 | $13,600,000 | 6,285,458 (Indirect) |
View |
| 2020-06-22 Purchase |
2020-06-24 7:00 pm |
LEAP THERAPEUTICS INC. | LPTX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
1,750,000 | $2 | $3,500,000 | 8,476,496 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-01 Option Award |
2021-02-03 7:15 pm |
N/A N/A |
CATABASIS PHARMACEUTICALS INC | CATB | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Xontogeny LLC Perceptive Xontogeny Venture Fund LP EDELMAN JOSEPH Director 10% Owner |
6,468 | $3,010 | 35,771 (Indirect) |
View |
Ownership |
2021-02-03 7:13 pm |
N/A N/A |
CATABASIS PHARMACEUTICALS INC | CATB | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Xontogeny LLC Perceptive Xontogeny Venture Fund LP EDELMAN JOSEPH Director 10% Owner |
0 | $0 | 40,013,924 (Indirect) |
View |
Ownership |
2021-02-03 7:12 pm |
N/A N/A |
Landos Biopharma Inc. | LABP | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Xontogeny LLC Perceptive Xontogeny Venture Fund LP EDELMAN JOSEPH Director 10% Owner |
0 | $0 | 16,460,652 (Indirect) |
View |
Ownership |
2021-01-26 9:14 pm |
N/A N/A |
SCYNEXIS INC | SCYX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
0 | $0 | 4,800,000 (Indirect) |
View |
| 2020-12-10 Option Award |
2020-12-15 8:21 pm |
N/A N/A |
Solid Biosciences Inc. | SLDB | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Director 10% Owner |
4,054,054 | $3.7 | 10,803,857 (Indirect) |
View |
| 2020-09-22 Conversion |
2020-09-22 7:11 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD 10% Owner |
1,644,785 | $0 | 3,114,805 (Indirect) |
View |
Ownership |
2020-09-17 9:05 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD 10% Owner |
0 | $0 | 2,083,723 (Indirect) |
View |
| 2020-06-16 Option Award |
2020-06-18 8:27 pm |
N/A 2030-06-16 |
Solid Biosciences Inc. | SLDB | PERCEPTIVE ADVISORS LLC EDELMAN JOSEPH Director 10% Owner |
30,000 | $0 | 30,000 (Indirect) |
View |